
Fraser
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
M&A advisory and investment firm, partnering with leaders in Europe’s B2B technology sectors to unlock next levels of growth & success.
Investor Profile
Fraser has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United Kingdom, France, Germany.
- Strong thematic focus on Health Care, Biotechnology, Artificial Intelligence (AI).
Stage Focus
- Series B (38%)
- Series Unknown (19%)
- Series A (13%)
- Seed (13%)
- Series C (6%)
- Debt Financing (6%)
- Pre Seed (6%)
Country Focus
- United Kingdom (38%)
- France (31%)
- Germany (13%)
- Australia (6%)
- United States (6%)
- The Netherlands (6%)
Industry Focus
- Health Care
- Biotechnology
- Artificial Intelligence (Ai)
- Machine Learning
- Therapeutics
- Compliance
- Hospital
- Software
- Cyber Security
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.